Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

Medchemexpress LLC Darifenacin (hydrobromide) | 133099-07-7 | 99.38% | C28H31BrN2O2 | 1 ML
SDP

Catalog No. 5000433073
Encompass_Preferred

Darifenacin hydrobromide, a selective M3 muscarinic receptor (M3R) antagonist, is provided as a 10 mM solution in 1 mL of DMSO. It is used in studies of urinary incontinence and overactive bladder symptoms. Research also highlights its ability to inhibit tumor growth in colorectal cancer cells, demonstrating anti-tumor effects.

  • Selective M3 muscarinic receptor antagonist
  • Potential for urinary incontinence and overactive bladder research
  • Inhibits tumor growth in colorectal cancer cells
  • Supplied as a 10 mM solution in 1 mL DMSO

Catalog No. 50-004-33073 Supplier Medchemexpress LLC Supplier No. HYA001210MM/1ML
May include imposed supplier surcharges.
Add to Cart
Add to Cart

Darifenacin hydrobromide, a selective M3 muscarinic receptor (M3R) antagonist, is provided as a 10 mM solution in 1 mL of DMSO. It is used in studies of urinary incontinence and overactive bladder symptoms. Research also highlights its ability to inhibit tumor growth in colorectal cancer cells, demonstrating anti-tumor effects.

  • Selective M3 muscarinic receptor antagonist
  • Potential for urinary incontinence and overactive bladder research
  • Inhibits tumor growth in colorectal cancer cells
  • Supplied as a 10 mM solution in 1 mL DMSO

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.